Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Extreme responses to immune checkpoint blockade following bipolar androgen therapy and enzalutamide in patients with metastatic castration resistant prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences